You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-B Raf antibody [EP152Y] (ab33899)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-B Raf antibody [EP152Y]
See all B Raf products (21) ...

Description

Rabbit monoclonal [EP152Y] to B Raf

Tested applications

WB, IHC-P, Flow Cyt, IPmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

Synthetic peptide: CGEHNPPSIYLEAYEEYT, corresponding to N terminal amino acids 70-86 of Human B Raf

CGEHNPPSIY LEAYEEYT

Positive control

HeLa cell lysate, human prostate cancer tissue. This antibody also reacts with rat brain tissue.

General notes

Produced under U.S. Patent No. 5,675,063.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.01% Sodium Azide
Constituents: 40% Glycerol, 0.05% BSA, 0.15M Sodium chloride, 50mM Tris glycine. pH 7.4

Concentration

Concentration information loading...

Clonality

Monoclonal

Clone number

EP152Y

Isotype

IgG

  • Western blot - B Raf antibody [EP152Y] (ab33899)Western blot - B Raf antibody [EP152Y] (ab33899) image (enlarge)

  • Immunohistochemistry (Paraffin-embedded sections) - B Raf antibody [EP152Y] (ab33899)Immunohistochemistry (Paraffin-embedded sections) - B Raf antibody [EP152Y] (ab33899) image (enlarge)

  • Western blot - B Raf antibody [EP152Y] (ab33899)Western blot - B Raf antibody [EP152Y] (ab33899) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab33899 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

Is unsuitable for or ICC.

Target

Function

Involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May play a role in the postsynaptic responses of hippocampal neuron.

Tissue specificity

Brain and testis.

Involvement in disease

Note=Defects in BRAF are found in a wide range of cancers.
Defects in BRAF may be a cause of colorectal cancer (CRC) [MIM:114500].
Defects in BRAF are involved in lung cancer (LNCR) [MIM:211980].
Defects in BRAF are involved in non-Hodgkin lymphoma (NHL) [MIM:605027]. NHL is a cancer that starts in cells of the lymph system, which is part of the body's immune system. NHLs can occur at any age and are often marked by enlarged lymph nodes, fever and weight loss.
Defects in BRAF are a cause of cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150]; also known as cardio-facio-cutaneous syndrome. CFC syndrome is characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. The inheritance of CFC syndrome is autosomal dominant.
Defects in BRAF are the cause of Noonan syndrome type 7 (NS7) [MIM:613706]. Noonan syndrome is a disorder characterized by facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears. Other features can include short stature, a short neck with webbing or redundancy of skin, cardiac anomalies, deafness, motor delay and variable intellectual deficits.
Defects in BRAF are the cause of LEOPARD syndrome type 3 (LEOPARD3) [MIM:613707]. LEOPARD3 is a disorder characterized by lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and sensorineural deafness.
Note=A chromosomal aberration involving BRAF is found in pilocytic astrocytomas. A tandem duplication of 2 Mb at 7q34 leads to the expression of a KIAA1549-BRAF fusion protein with a constitutive kinase activity and inducing cell transformation.

Sequence similarities

Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.
Contains 1 phorbol-ester/DAG-type zinc finger.
Contains 1 protein kinase domain.
Contains 1 RBD (Ras-binding) domain.

Cellular localization

Nucleus. Cytoplasm. Cell membrane. Colocalizes with RGS14 and RAF1 in both the cytoplasm and membranes.

Target information above from: UniProt accessionP15056 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • FLJ95109 antibody
  • Murine sarcoma viral (v-raf) oncogene homolog B1 antibody
  • 94 kDa B raf protein antibody
  • B raf 1 antibody
  • B raf 1 antibody
  • B Raf proto oncogene serine threonine protein kinase antibody
  • B Raf proto oncogene serine threonine protein kinase antibody
  • BRAF 1 antibody
  • BRaf antibody
  • BRaf antibody
  • BRAF_HUMAN antibody
  • BRAF1 antibody
  • BRAF1 antibody
  • cRmil antibody
  • MGC126806 antibody
  • MGC138284 antibody
  • Murine sarcoma viral (v-raf) oncogene homolog B1 antibody
  • Murine sarcoma viral v raf oncogene homolog B1 antibody
  • Murine sarcoma viral v raf oncogene homolog B1 antibody
  • NS7 antibody
  • p94 antibody
  • p94 antibody
  • Proto-oncogene B-Raf antibody
  • RAFB 1 antibody
  • RAFB1 antibody
  • RAFB1 antibody
  • Serine/threonine-protein kinase B-raf antibody
  • v raf murine sarcoma viral oncogene homolog B1 antibody
  • v raf murine sarcoma viral oncogene homolog B1 antibody
  • v-Raf murine sarcoma viral oncogene homolog B1 antibody
see all

Anti-B Raf antibody [EP152Y] images:

  Western blot - B Raf antibody [EP152Y] (ab33899)

Western blot - B Raf antibody [EP152Y] (ab33899)

Anti-B Raf antibody [EP152Y] (ab33899) at 1/5000 dilution + HeLa cell lysate

Predicted band size : 85 kDa
Observed band size : 87 kDa (why is the actual band size different from the predicted?)

  Immunohistochemistry (Paraffin-embedded sections) - B Raf antibody [EP152Y] (ab33899)

Immunohistochemistry (Paraffin-embedded sections) - B Raf antibody [EP152Y] (ab33899)

This image shows paraffin embedded human prostate cancer tissue sample stained with ab33899 at 1/250 dilution.

  Western blot - B Raf antibody [EP152Y] (ab33899)

Western blot - B Raf antibody [EP152Y] (ab33899)

All lanes : Anti-B Raf antibody [EP152Y] (ab33899) at 1/1000 dilution

Lane 1 : Lysate prepared from mouse brain
Lane 2 : Lysate prepared from mouse heart
Lane 3 : Lysate prepared from mouse kidney
Lane 4 : Lysate prepared from mouse spleen
Lane 5 : Lysate prepared from rat brain
Lane 6 : Lysate prepared from rat heart
Lane 7 : Lysate prepared from rat kidney
Lane 8 : Lysate prepared from rat spleen


Predicted band size : 85 kDa


Exposure time : 3 minutes

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - B Raf antibody [EP152Y] (ab33899)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - B Raf antibody [EP152Y] (ab33899)

ab33899 staining B Raf cells from human prostate tissue by immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections). Cells were formaldehyde fixed and permeabilized in PBS-Tween 20 prior to blocking in 70% serum for 10 minutes at 25°C. The primary antibody was diluted 1/250 and incubated with the sample for 1 hour at 25°C. A biotin conjugated goat polyclonal to mouse Ig was used as the secondary.

This image is courtesy of an Abreview submitted by Sedar Balci

See Abreview

References for Anti-B Raf antibody [EP152Y] (ab33899)

This product has been referenced in:

  • Blasco RBet al. c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma. Cancer Cell 19:652-63 (2011). IHC-P; Mouse.Read more (PubMed: 21514245) »
  • Yu Jet al. Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology 73:1526-31 (2009).Read more (PubMed: 19794125) »

See all 3 publications for this product

Publishing research using ab33899? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"